Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
CONSOLIDATED STATEMENTS OF OPERATIONS        
Revenue $ 502 $ 157 $ 1,263 $ 157
Operating expenses        
Research and development (20,460) (25,511) (41,724) (47,530)
General and administrative (10,295) (10,148) (19,556) (21,921)
Total operating expenses (30,755) (35,659) (61,280) (69,451)
Operating loss (30,253) (35,502) (60,017) (69,294)
Interest income 1,147 757 1,877 1,709
Other (expense) income, net (749) (6,277) 188 (847)
Loss before income taxes (29,855) (41,022) (57,952) (68,432)
Income tax expense (25) (65) (95) (67)
Net loss attributable to ordinary shareholders $ (29,880) $ (41,087) $ (58,047) $ (68,499)
Net loss per ordinary share - Basic and diluted        
Basic and diluted (in dollars per share) $ (0.04) $ (0.07) $ (0.07) $ (0.11)
Weighted average shares outstanding:        
Basic and diluted (in shares) 822,725,556 629,355,975 781,235,457 628,655,278